<DOC>
	<DOCNO>NCT01317966</DOCNO>
	<brief_summary>The purpose study determine whether Recombinant Human Interleukin-11 ( rhIL-11 ) Combination Low-dose Rituximab prednisone effective safe management Steroid-Resistant/Relapsed Immune Thrombocytopenia ( ITP ) .</brief_summary>
	<brief_title>Recombinant Human Interleukin-11 Combination Low-dose Rituximab Immune Thrombocytopenia</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Oprelvekin</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>1 . Patients may male female , age 16 ~ 75 year old . 2 . Isolated thrombocytopenia otherwise normal peripheral blood smear cause thrombocytopenia , morphologically normal bone marrow aspirate normal increased number megakaryocyte , absence splenomegaly . 3 . To show platelet count ≤ 30 × 109/L , platelet count ≥ 30 × 109/L bleed manifestation moment first infusion study product . 4 . ＥＣＯＧ performance status ≤ 2 . 5 . Patients fail respond acceptable dose steroid 4 week , relapse . Some patient also refractory splenectomy . 6 . Patients must willing able give write informed consent . 1 . Received chemotherapy anticoagulant drug affect platelet count within 3 month screen visit . 2 . Received secondline ITPspecific treatment ( eg , cyclophosphamide , 6mercaptopurine , vincristine , vinblastine , etc ) within 3 month screen visit . 3 . Received highdose steroid IVIG 3 week prior start study . 4 . Current HIV infection hepatitis B virus hepatitis C virus infection . 5 . Severe medical condition ( lung , hepatic renal disorder ) chronic ITP . Unstable uncontrolled disease condition relate impacting cardiac function ( e.g. , unstable angina , congestive heart failure , uncontrolled hypertension cardiac arrhythmia ) . 6 . Female patient nurse pregnant , may pregnant , contemplate pregnancy study period . 7 . Have know diagnosis autoimmune disease , establish medical history laboratory finding positive result determination antinuclear antibody , anticardiolipin antibody , lupus anticoagulant direct Coombs test . 8 . Patients deem unsuitable study investigator ( coinvestigator ) .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>